식품 바이오테크놀러지 시장 예측(-2034년) : 제품 유형, 원료, 기술, 용도, 최종사용자, 유통 채널, 지역별 세계 분석

According to Stratistics MRC, the Global Food Biotechnology Market is accounted for $35.0 billion in 2026 and is expected to reach $75.0 billion by 2034 growing at a CAGR of 9.9% during the forecast period. Food biotechnology refers to the application of biological systems, living organisms, and their derivatives to modify, process, and enhance food products. It functions by utilizing microbial fermentation, enzyme technology, and genetic engineering to improve nutritional value, extend shelf life, and develop alternative protein sources. These technologies encompass industrial enzymes, probiotics, and cultivated meat production. Their continuous application ensures sustainable food production, supporting global food security and innovative dietary solutions globally.

Market Dynamics:

Driver:

Escalating Demand for Sustainable and Alternative Protein Sources

The escalating global demand for sustainable and alternative protein sources compels manufacturers to adopt advanced food biotechnology solutions offering enhanced nutritional alternatives. Growing awareness of environmental impact is accelerating the integration of these biological formulations into daily food production routines. This transition is supported by advancements in fermentation technology, which enhance ingredient efficacy. Consequently, manufacturers are investing in specialized biological technologies to achieve compliance with stringent sustainability standards while optimizing consumer wellness costs.

Restraint:

Complex Regulatory Approvals for Genetically Modified Organisms

The substantial compliance costs associated with formulating advanced food biotechnology products represent a significant barrier to widespread commercial expansion. Developing highly effective and safe biological blends often requires complex toxicological assessments and sophisticated quality control techniques, which escalate overall production costs. Furthermore, the sensitivity of certain active ingredients to strict environmental regulations limits their operational viability in diverse global markets. These factors collectively constrain growth, particularly for enterprises with limited research budgets.

Opportunity:

Expansion in CRISPR and Advanced Gene Editing

The CRISPR and advanced gene editing sector presents substantial growth opportunities for food biotechnology manufacturers due to increasing demand for sustainable crop enhancement. Advanced genetic formulations offer a highly effective pathway to improve crop yields without relying on traditional breeding, utilizing precise molecular tools as primary inputs. As global investments in agricultural biotechnology expand and regulatory agencies favor green pathways, the adoption of advanced gene editing solutions is expected to surge significantly.

Threat:

Consumer Skepticism Regarding Genetically Modified Foods

The continuous proliferation of traditional agricultural methods and emerging conventional farming providers poses a considerable threat to the food biotechnology market. Conventional organic farming and emerging sustainable agriculture systems often exhibit superior consumer acceptance under current economic conditions and can be more economically viable for environmentally conscious consumers. Additionally, the rapid advancement of basic farming technology is enhancing the efficiency of conventional agricultural methods. This competitive pressure may hinder penetration.

Covid-19 Impact:

The pandemic initially disrupted food biotechnology supply chains and delayed research expansions due to logistical constraints. However, the subsequent surge in food security accelerated the adoption of advanced biological solutions for essential daily nutrition. Post-pandemic, the heightened focus on personal health and sustainability has reinforced long-term investments in food biotechnology, driving robust recovery across diverse consumer sectors globally.

The industrial enzymes segment is expected to be the largest during the forecast period

The industrial enzymes segment is expected to account for the largest market share during the forecast period, due to its unparalleled daily necessity and widespread applicability across diverse food production demographics. Industrial enzymes offer exceptional catalytic capabilities and operate effectively in processing raw materials, which significantly reduces production time and minimizes energy consumption in daily routines. As consumers increasingly prioritize foundational and cost-effective production methods, the demand for specialized enzyme formulations continues to surge, solidifying their dominant position.

The CRISPR and advanced gene editing segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the CRISPR and advanced gene editing segment is predicted to witness the highest growth rate, driven by rapid advancements in biological material science and genetic engineering. These technologies enable the precise modification of crop DNA to produce highly specialized and robust environmental outputs tailored for specific ecological applications. The ability to enhance crop yield, operational stability, and biocompatibility through advanced genetic integration significantly improves process economics, accelerating commercial adoption globally.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the presence of well-established consumer goods industries and advanced retail infrastructure that heavily utilize premium food biotechnology products. The region benefits from substantial research and development investments, robust intellectual property protection, and supportive government initiatives promoting consumer safety and product quality. Furthermore, the early adoption of advanced biological formulations by key industry players in the United States and Canada reinforces the region's dominant position globally.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapid urbanization and expanding personal care sectors in emerging economies. Countries such as China, India, and Japan are increasingly investing in food biotechnology infrastructure and sustainable agricultural technologies to meet growing domestic nutritional demands and stringent environmental regulations. Additionally, favorable government policies, rising foreign direct investment, and the availability of cost-effective agricultural resources are collectively driving the accelerated adoption of food biotechnology across the region.

Key players in the market

Some of the key players in Food Biotechnology Market include Novonesis, DSM-Firmenich, Givaudan S.A., International Flavors & Fragrances (IFF), Kerry Group plc, Cargill, Incorporated, Archer Daniels Midland Company (ADM), Tate & Lyle PLC, Corbion N.V., Lallemand Inc., AB Enzymes GmbH, Amano Enzyme Inc., Nagase & Co., Ltd., Danisco (part of IFF), Biocatalysts Ltd., Perfect Day, Inc., Upside Foods, and Impossible Foods Inc.

Key Developments:

In September 2026, Novonesis (formerly Novozymes and Chr. Hansen) launched a next-generation industrial enzyme optimized for plant-based protein extraction, achieving a thirty percent improvement in yield efficiency while significantly reducing energy consumption requirements for global food manufacturing.

In August 2026, DSM-Firmenich expanded its probiotic fermentation capacity through a strategic partnership with a leading microbiome firm, enabling the scalable deployment of novel gut health modules for daily nutritional synthesis.

In July 2026, Givaudan S.A. secured a major supply agreement to provide customized flavor enhancement biocatalysts for a prominent food producer, facilitating the efficient integration of advanced taste profiling tools into next-generation consumer ecosystems globally.

In June 2026, International Flavors & Fragrances (IFF) received regulatory clearance for its proprietary cultivated meat platform, accelerating the development of highly specific cellular agriculture formulations designed to streamline complex alternative protein production processes worldwide.

In May 2026, Kerry Group plc inaugurated a new state-of-the-art food biotechnology research and development center in Asia, focusing on the discovery and optimization of novel CRISPR crop enhancement technologies for the agricultural markets.

Product Types Covered:

• Industrial Enzymes
• Microorganisms and Probiotics
• Amino Acids and Organic Acids
• Vitamins and Bioactive Compounds
• Bio-preservatives and Natural Antimicrobials

Sources Covered:

• Microbial
• Plant-Derived
• Animal-Derived
• Synthetic Biology and Lab-Grown

Technologies Covered:

• Fermentation and Microbial Processing
• Genetic Engineering and GMOs
• Enzyme Technology and Biocatalysis
• Cell Culture and Cultivated Meat Technology
• CRISPR and Advanced Gene Editing

Applications Covered:

• Food Processing and Preservation
• Flavor and Fragrance Enhancement
• Nutritional Fortification and Enhancement
• Food Safety, Pathogen Detection, and Testing
• Alternative Protein and Meat Substitute Production

End Users Covered:

• Dairy and Alternative Dairy Products
• Meat, Poultry, and Seafood Processing
• Bakery and Confectionery
• Beverage Production
• Functional Foods and Dietary Supplements

Distribution Channels Covered:

• B2B Direct Sales to Food Manufacturers
• Distributors and Wholesalers
• Online B2B Platforms and Marketplaces
• Contract Research and Manufacturing Organizations (CROs/CMOs)

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Food Biotechnology Market, By Product Type

• 5.1 Industrial Enzymes
• 5.2 Microorganisms and Probiotics
• 5.3 Amino Acids and Organic Acids
• 5.4 Vitamins and Bioactive Compounds
• 5.5 Bio-preservatives and Natural Antimicrobials

6 Global Food Biotechnology Market, By Source

• 6.1 Microbial
• 6.2 Plant-Derived
• 6.3 Animal-Derived
• 6.4 Synthetic Biology and Lab-Grown

7 Global Food Biotechnology Market, By Technology

• 7.1 Fermentation and Microbial Processing
• 7.2 Genetic Engineering and GMOs
• 7.3 Enzyme Technology and Biocatalysis
• 7.4 Cell Culture and Cultivated Meat Technology
• 7.5 CRISPR and Advanced Gene Editing

8 Global Food Biotechnology Market, By Application

• 8.1 Food Processing and Preservation
• 8.2 Flavor and Fragrance Enhancement
• 8.3 Nutritional Fortification and Enhancement
• 8.4 Food Safety, Pathogen Detection, and Testing
• 8.5 Alternative Protein and Meat Substitute Production

9 Global Food Biotechnology Market, By End User

• 9.1 Dairy and Alternative Dairy Products
• 9.2 Meat, Poultry, and Seafood Processing
• 9.3 Bakery and Confectionery
• 9.4 Beverage Production
• 9.5 Functional Foods and Dietary Supplements

10 Global Food Biotechnology Market, By Distribution Channel

• 10.1 B2B Direct Sales to Food Manufacturers
• 10.2 Distributors and Wholesalers
• 10.3 Online B2B Platforms and Marketplaces
• 10.4 Contract Research and Manufacturing Organizations (CROs/CMOs)

11 Global Food Biotechnology Market, By Geography

• 11.1 North America
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Mexico
• 11.2 Europe
  • 11.2.1 United Kingdom
  • 11.2.2 Germany
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Netherlands
  • 11.2.7 Belgium
  • 11.2.8 Sweden
  • 11.2.9 Switzerland
  • 11.2.10 Poland
  • 11.2.11 Rest of Europe
• 11.3 Asia Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 South Korea
  • 11.3.5 Australia
  • 11.3.6 Indonesia
  • 11.3.7 Thailand
  • 11.3.8 Malaysia
  • 11.3.9 Singapore
  • 11.3.10 Vietnam
  • 11.3.11 Rest of Asia Pacific
• 11.4 South America
  • 11.4.1 Brazil
  • 11.4.2 Argentina
  • 11.4.3 Colombia
  • 11.4.4 Chile
  • 11.4.5 Peru
  • 11.4.6 Rest of South America
• 11.5 Rest of the World (RoW)
  • 11.5.1 Middle East
    • 11.5.1.1 Saudi Arabia
    • 11.5.1.2 United Arab Emirates
    • 11.5.1.3 Qatar
    • 11.5.1.4 Israel
    • 11.5.1.5 Rest of Middle East
  • 11.5.2 Africa
    • 11.5.2.1 South Africa
    • 11.5.2.2 Egypt
    • 11.5.2.3 Morocco
    • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

• 12.1 Industry Value Network and Supply Chain Assessment
• 12.2 White-Space and Opportunity Mapping
• 12.3 Product Evolution and Market Life Cycle Analysis
• 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

• 13.1 Mergers and Acquisitions
• 13.2 Partnerships, Alliances, and Joint Ventures
• 13.3 New Product Launches and Certifications
• 13.4 Capacity Expansion and Investments
• 13.5 Other Strategic Initiatives

14 Company Profiles

• 14.1 Novonesis
• 14.2 DSM-Firmenich
• 14.3 Givaudan S.A.
• 14.4 International Flavors & Fragrances (IFF)
• 14.5 Kerry Group plc
• 14.6 Cargill, Incorporated
• 14.7 Archer Daniels Midland Company (ADM)
• 14.8 Tate & Lyle PLC
• 14.9 Corbion N.V.
• 14.10 Lallemand Inc.
• 14.11 AB Enzymes GmbH
• 14.12 Amano Enzyme Inc.
• 14.13 Nagase & Co., Ltd.
• 14.14 Danisco (part of IFF)
• 14.15 Biocatalysts Ltd.
• 14.16 Perfect Day, Inc.
• 14.17 Upside Foods
• 14.18 Impossible Foods Inc.